Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Clinical trials in stroke prevention.

¹John P. Robarts Research Institute, London, Ontario, Canada.

Arzneimittel-Forschung

|March 1, 1991

Summary

This summary is machine-generated.

Randomized clinical trials are essential for evaluating stroke prevention treatments. Anticoagulants and aspirin are proven effective for specific conditions, while other treatments require further evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

1. Design and main results of the trial.

Canadian Medical Association journal·2010

Same author

Surgery was beneficial for severe carotid stenosis in patients with symptomatic carotid ischemia.

Evidence-based cardiovascular medicine·2005

Same author

Carotid angioplasty/stenting versus endarterectomy.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2001

Same author

Thrombolysis must be considered after stroke.

BMJ (Clinical research ed.)·2001

Same author

Prognosis after transient monocular blindness associated with carotid-artery stenosis.

The New England journal of medicine·2001

Same author

Stroke: 30 years of progress: 1982-1987.

Stroke·2001

Area of Science:

Neurology
Cardiology
Clinical Trials

Background:

Randomized clinical trials (RCTs) are the gold standard for evaluating stroke prevention and treatment strategies.
Non-randomized comparisons and data banks have limitations in assessing treatment efficacy for stroke patients.
Over 35 years, RCT methodologies have improved, enhancing reliability in stroke research.

Purpose of the Study:

To evaluate the effectiveness of various treatments for preventing ischemic stroke.
To assess the role of anticoagulants, antiplatelet agents, and surgical interventions in stroke prevention.
To establish benchmarks for judging the efficacy of stroke treatments.

Main Methods:

Review of existing randomized clinical trials on stroke prevention.

Related Experiment Videos

Analysis of data from trials evaluating anticoagulants, acetylsalicylic acid, ticlopidine, and other agents.

Evaluation of surgical interventions like cerebral by-pass and carotid endarterectomy.

Main Results:

Anticoagulants are effective for stroke prevention in non-rheumatic atrial fibrillation and post-myocardial infarction.
Acetylsalicylic acid (325-1300 mg/d) is proven effective for stroke prevention; lower doses lack evidence.
Ticlopidine demonstrates efficacy; dipyridamole, suloctidil, and sulfinpyrazone benefits are unproven. Cerebral by-pass surgery is not effective for arteriosclerotic cerebrovascular disease.
Carotid endarterectomy efficacy is still under evaluation.

Conclusions:

RCTs are indispensable for stroke prevention and treatment evaluation.
Established treatments include anticoagulants for specific conditions and higher-dose aspirin.
Further research is needed for other pharmacological and surgical interventions in stroke prevention.